Sloan Sheldon bought SYRE
January 15, 2025 · Form 4 insider transaction
Sloan Sheldon bought 95,500 shares of Spyre Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
95,500
Price
$0.00
Total value
N/A
InsiderSloan Sheldon
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 15, 2025
Filing dateJanuary 17, 2025
Shares owned after95,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase 95,500 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.